First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 589-591

  Espinal, P ^a   Macia M D ^b   Roca, I ^a   Gato, E ^c   Ruiz E ^b   Fernandez Cuenca F ^d   Oliver, A ^b   Rodriguez Bano J ^d   Bou, G ^c   Tomas M ^c   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c Aging and Inflammation Research Lab   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL ENZYME; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; OXA 23 ENZYME; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; SPAIN; SPUTUM ANALYSIS; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHROMOSOMES, BACTERIAL; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SPAIN;

EID: 84872022259     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01157-12     Document Type: Article

References (21)

1. Antunes LC, Imperi F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6:e22674. doi:10.1371/journal.pone.0022674.
2. Roca I, Espinal P, Vila-Farres X, Vila J. 2012. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front. Microbiol. 3:148.
3. Espinal P, Marti S, Vila J. 2012. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J. Hosp. Infect. 80:56-60.
4. Kohlenberg A, Brummer S, Higgins PG, Sohr D, Piening BC, de Grahl C, Halle E, Ruden H, Seifert H. 2009. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J. Med. Microbiol. 58:1499-1507.
5. CLSI. 2011. Performance standards for antimicrobial susceptibility testing, 15th informational supplement, M100-515. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Ellington MJ, Kistler J, Livermore DM, Woodford N. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59:321-322.
7. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119-123.
8. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.
9. Espinal P, Fugazza G, López Y, Kasma M, Lerman Y, Malhotra-Kumar S, Goossens H, Carmeli Y, Vila J. 2011. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55:5396-5398.
10. OXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:1530-1533.
11. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35-40.
12. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. 2007. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13:807-815.
13. Nemec A, Krizova L, Maixnerova M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L. 2008. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J. Antimicrob. Chemother. 62:484-489.
14. Bou G, Oliver A, Martinez-Beltrán J. 2000. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561.
15. Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. 2007. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin. Microbiol. Infect. 13:1192-1198.
16. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef AP, Asensi MD, Peixe L. 2011. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J. Antimicrob. Chemother. 66:62-65.
17. Grosso F, Quinteira S, Peixe L. 2011. Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal. Clin. Microbiol. Infect. 17:1275-1279.
18. Minandri F, D'Arezzo S, Antunes LC, Pourcel C, Principe L, Petrosillo N, Visca P. 2012. Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J. Clin. Microbiol. 50:590-597.
19. D'Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. 2011. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J. Antimicrob. Chemother. 66:54-61.
20. Liakopoulos A, Miriagou V, Katsifas EA, Karagouni AD, Daikos GL, Tzouvelekis LS, Petinaki E. 2012. Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill. 17(11):20117.
21. OXA-58 carbapenemase- encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int. J. Antimicrob. Agents 40:89-91.